FDA Approves Tremfya for Active Crohn Disease in Adults
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease ...
F.D.A. Approved Lab-Grown Blood Vessel Despite Warnings
The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...
'I'm 40 but everyone mistakes me for 20 - here's how I look sexy and energised'
Kera, who is in her 40s but is often mistaken for a woman in her 20s, has shared her secret to maintaining a youthful ...
FDA OKs Amvuttra To Treat Heart Conditions
ATTR-CM is a disease in which harmful proteins build up in the heart, making it harder to pump blood, according to the ...
Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...